Featured Content
Grand Junction, Colo.-based Intermountain Health is now offering eligible patients with metastatic pancreatic cancer access to daraxonrasib, an investigational therapy…
Grand Junction, Colo.-based Intermountain Health is now offering eligible patients with metastatic pancreatic cancer access to daraxonrasib, an investigational therapy…